A Multi-omics Study of "Healthy" Premature CAD Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Multi-omics Study of "Healthy" Premature CAD Patients — Stella

Recruiting

Back to Coronary Artery Disease trials

Trial locations(3 sites)

China

First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu

Qilu Hospital of Shangdong University, Jinan, Shandong

The Second Affiliated Hospital of Zhejiang University Medical College, Hangzhou, Zhejiang

Key details

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment target

~160 participants

Started

March 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov